Extend EARLY Act Authorization to 2031

Full Title:
EARLY Act Reauthorization of 2025

Summary#

This bill changes one line of federal law to extend the end date for the Young Women’s Breast Health Education and Awareness (EARLY) Act. It replaces the current authorization end year of 2026 with 2031. The bill does not change any other program text or funding amounts in the law.

  • Main change: extends the authorization period for the EARLY Act from 2026 to 2031.
  • Policy goal: keep the EARLY Act authorities in place for five more years so the program can continue operating.
  • What it does not do: does not change funding levels, program duties, eligibility, or reporting requirements in the text provided.

What it means for you#

  • Young people targeted by the EARLY Act: This could mean continued federal authority for programs aimed at breast health education and awareness for younger women, so outreach or education that exists under the EARLY Act can continue if funded.
  • Organizations that run the program (states, health departments, nonprofits, clinics): Likely to benefit from continuity of authorization; the bill itself does not promise new grants or money.
  • Congress and federal agencies: The agencies that administer the EARLY Act will have authorization to operate the program through 2031 unless Congress or the agencies change policy or funding.
  • General public: No immediate change to services or taxes is spelled out in the bill text; practical effects depend on whether Congress provides funding in future appropriations.

What is unclear: The bill text does not say whether Congress will increase, decrease, or keep funding the same. It also does not describe any program changes beyond the date.

Expenses#

No publicly available information.

  • The bill changes only the authorization end date. It does not state dollar amounts or create new spending rules.
  • Because it does not specify funding levels, there is no direct cost estimate in the bill text provided. Continued spending would depend on future appropriations by Congress.
  • Administrative or compliance costs are not addressed in the text.

Proponents' View#

  • The bill appears intended to keep the EARLY Act authority in place for five more years so related education and awareness activities can continue without a lapse.
  • A possible argument for the bill is that continuing authorization supports ongoing public-health outreach aimed at young women’s breast health.
  • It could be seen as a simple, low-friction way to maintain existing programs while Congress considers longer-term policy or funding decisions.

Opponents' View#

  • One concern is that the bill only extends the date and does not provide updated funding amounts or new oversight, so it delays any re-evaluation of the program’s effectiveness.
  • The lack of a fiscal note or cost estimate makes it hard to judge the budgetary impact if appropriations follow the authorization.
  • Extending authorization without program changes may leave unresolved problems in program design or delivery unaddressed.